Aspect's platform technology constitutes an entirely new way of 3D bioprinting, engineered specifically with the capacity to fabricate physiologically complex living tissue on demand for broad applications in the life sciences. We have developed a sophisticated Lab-on-a-printer™ technology that enables unprecedented control over biomaterial composition and structure during tissue fabrication.